Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Thomas

Showing results (171-180 of 438) with videos related to

Pageof 44
Sort By:
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|July 20, 2018
Immune check point inhibitors for metastatic urothelial carcinoma: current evidence-based approach for urology daily practiceNikita D Nabar, Maximilian P Brandt, Christian Thomas, et al.
Frontiers in Neurology|June 12, 2018
A Novel PKD1 Mutation Associated With Autosomal Dominant Kidney Disease and Cerebral Cavernous MalformationChristian Thomas, Andrea Zühlsdorf, Konstanze Hörtnagel, et al.
BJU International|May 20, 2011
Predictors for clinically relevant Gleason score upgrade in patients undergoing radical prostatectomyChristian Thomas, Karin Pfirrmann, Frauke Pieles, et al.
Urologia Internationalis|December 29, 2021
Decreasing Number of Urodynamics in Urological and Gynaecological Clinics Reflects Decreased Importance for Surgical Indications: German Population-Based Data from 2013 to 2019Martin Baunacke, Isabel Leuchtweis, Albert Kaufmann, et al.
Diagnostics (Basel, Switzerland)|August 14, 2020
Evaluation of MicroRNAs as Non-Invasive Diagnostic Markers in Urinary Cells from Patients with Suspected Prostate CancerAngelika Borkowetz, Andrea Lohse-Fischer, Jana Scholze, et al.
International Urology and Nephrology|July 11, 2025
Adherence to post-therapeutic multidisciplinary tumor board recommendation and its influence on oncological outcomes in high-risk prostate cancer patients following radical prostatectomyBenedikt Hoeh, Jeremy Kwe, Fabian Schreiber, et al.
The Journal of Clinical Endocrinology and Metabolism|May 19, 2020
HMGA2 Variants in Silver-Russell Syndrome: Homozygous and Heterozygous OccurrenceChristian Thomas Hübner, Robert Meyer, Asmaa Kenawy, et al.
Urologia Internationalis|October 23, 2019
Socioeconomic Status-Related Parameters as Predictors of Competing (Non-Bladder Cancer) Mortality after Radical CystectomyMichael Froehner, David Muallah, Rainer Koch, et al.
Life Sciences|February 2, 2016
Amygdalin delays cell cycle progression and blocks growth of prostate cancer cells in vitroJasmina Makarević, Igor Tsaur, Eva Juengel, et al.
Frontiers in Molecular Biosciences|July 15, 2022
Influence of Androgen Deprivation Therapy on the PD-L1 Expression and Immune Activity in Prostate Cancer TissueUlrich Sommer, Celina Ebersbach, Alicia-Marie K Beier, et al.
Pageof 44

Showing results (171-180 of 438) with videos related to

Sort By:
Pageof 44
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|July 20, 2018
Immune check point inhibitors for metastatic urothelial carcinoma: current evidence-based approach for urology daily practiceNikita D Nabar, Maximilian P Brandt, Christian Thomas, et al.
Frontiers in Neurology|June 12, 2018
A Novel PKD1 Mutation Associated With Autosomal Dominant Kidney Disease and Cerebral Cavernous MalformationChristian Thomas, Andrea Zühlsdorf, Konstanze Hörtnagel, et al.
BJU International|May 20, 2011
Predictors for clinically relevant Gleason score upgrade in patients undergoing radical prostatectomyChristian Thomas, Karin Pfirrmann, Frauke Pieles, et al.
Urologia Internationalis|December 29, 2021
Decreasing Number of Urodynamics in Urological and Gynaecological Clinics Reflects Decreased Importance for Surgical Indications: German Population-Based Data from 2013 to 2019Martin Baunacke, Isabel Leuchtweis, Albert Kaufmann, et al.
Diagnostics (Basel, Switzerland)|August 14, 2020
Evaluation of MicroRNAs as Non-Invasive Diagnostic Markers in Urinary Cells from Patients with Suspected Prostate CancerAngelika Borkowetz, Andrea Lohse-Fischer, Jana Scholze, et al.
International Urology and Nephrology|July 11, 2025
Adherence to post-therapeutic multidisciplinary tumor board recommendation and its influence on oncological outcomes in high-risk prostate cancer patients following radical prostatectomyBenedikt Hoeh, Jeremy Kwe, Fabian Schreiber, et al.
The Journal of Clinical Endocrinology and Metabolism|May 19, 2020
HMGA2 Variants in Silver-Russell Syndrome: Homozygous and Heterozygous OccurrenceChristian Thomas Hübner, Robert Meyer, Asmaa Kenawy, et al.
Urologia Internationalis|October 23, 2019
Socioeconomic Status-Related Parameters as Predictors of Competing (Non-Bladder Cancer) Mortality after Radical CystectomyMichael Froehner, David Muallah, Rainer Koch, et al.
Life Sciences|February 2, 2016
Amygdalin delays cell cycle progression and blocks growth of prostate cancer cells in vitroJasmina Makarević, Igor Tsaur, Eva Juengel, et al.
Frontiers in Molecular Biosciences|July 15, 2022
Influence of Androgen Deprivation Therapy on the PD-L1 Expression and Immune Activity in Prostate Cancer TissueUlrich Sommer, Celina Ebersbach, Alicia-Marie K Beier, et al.
Pageof 44